Crestanil en es it fr

Crestanil Brand names, Crestanil Analogs

Crestanil Brand Names Mixture

  • No information avaliable

Crestanil Chemical_Formula


Crestanil RX_link

No information avaliable

Crestanil fda sheet

Crestanil msds (material safety sheet)

Crestanil Synthesis Reference

No information avaliable

Crestanil Molecular Weight

309.469 g/mol

Crestanil Melting Point

< 25 oC

Crestanil H2O Solubility

Soluble as HCl salt

Crestanil State


Crestanil LogP


Crestanil Dosage Forms

Tablets (oral, 1 mg)

Crestanil Indication

Used for the symptomatic treatment of parkinsonism.

Crestanil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Crestanil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Crestanil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Crestanil Patient Information

Crestanil Organisms Affected

Humans and other mammals